Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows that the study is no longer recruiting participants, signaling closed enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0.SummaryDifference0.2%

- Check23 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, indicating a small page version update. No other visible content changes are indicated.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, signaling a maintenance update. No study content or functionality appears to be altered.SummaryDifference0.1%

- Check66 days agoChange DetectedThis updates the page’s software/UI revision marker from **v3.5.0** to **v3.5.3**.SummaryDifference0.1%

- Check80 days agoChange DetectedUI refresh of the study details page with updated layout and navigation; core study information such as eligibility criteria and outcomes remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.